3052 — APEX Science & Engineering Balance Sheet
0.000.00%
- TWD2.17bn
- TWD4.25bn
- TWD3.42bn
Annual balance sheet for APEX Science & Engineering, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 298 | 304 | 240 | 612 | 848 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,991 | 4,334 | 4,568 | 5,500 | 4,335 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,495 | 8,727 | 7,037 | 9,614 | 13,227 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 127 | 124 | 124 | 92.2 | 91.6 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,166 | 9,374 | 7,630 | 10,028 | 13,476 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,544 | 5,622 | 3,701 | 6,010 | 9,861 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5,170 | 6,239 | 4,372 | 6,632 | 9,962 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,996 | 3,136 | 3,258 | 3,396 | 3,514 |
| Total Liabilities & Shareholders' Equity | 8,166 | 9,374 | 7,630 | 10,028 | 13,476 |
| Total Common Shares Outstanding |